Historical record - last NADAC effective date: 4/24/2015
Product Information
TASMAR 100 MG TABLET is a brand product labeled by Bausch Health US LLC, priced at $105.9846 per EA under NDC 00187093801. Its NADAC has been published 129 times since Nov 28, 2013.
FDA first approved this application on Jan 29, 1998.
Strength
100 mg/1
Manufacturer
Bausch Health US LLCNDC
00187093801
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
4/24/2015
Active Ingredients
TOLCAPONEApproval Type
New Drug (NDA)
FDA Application
NDA020697FDA Approved
1/29/1998
On Market Since
7/27/2004
Pharmacological Classes
Price Statistics
The NADAC for TASMAR 100 MG TABLET has been published 129 times since Nov 28, 2013, and over the history we have for it it has risen 575.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $105.9846 per EA |
|---|---|
| All-time high | $105.9846 (May 11, 2016) |
| All-time low | $15.7015 (Nov 28, 2013) |
| Median price | $64.2915 |
| Average price | $66.2614 |
| Largest weekly change | +50.0% (Jul 23, 2014) |
| Weeks tracked | 129 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+575.0%
Last surveyed May 11, 2016 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Tolcapone market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Bausch Health US LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Tolcapone market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Catechol-O-Methyltransferase Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TASMAR 100 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TASMAR 100 MG TABLET, manufactured by Bausch Health US LLC, is $105.9846 per EA (NDC 00187093801), effective May 11, 2016.
How has the price of TASMAR 100 MG TABLET changed over time?
Over the history we have for it, the NADAC for TASMAR 100 MG TABLET has risen 575.0%. It has been tracked across 129 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for TASMAR 100 MG TABLET?
Since Nov 28, 2013, the NADAC for TASMAR 100 MG TABLET has ranged from a low of $15.7015 (Nov 28, 2013) to a high of $105.9846 (May 11, 2016), with a median of $64.2915 per EA.
Are there cheaper alternatives to TASMAR 100 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of TASMAR 100 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures TASMAR 100 MG TABLET?
TASMAR 100 MG TABLET (NDC 00187093801) is labeled by Bausch Health US LLC, and CMS classifies it as a brand product.